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Two forms of a neutral protease that catalyzed the hydrolysis of succinyl-Leu-Leu-Vai-Tyr-MC were 
isolated from porcine skeletal muscle cytosol by fractionation on DEAE-cellulose, hy~oxyapatite and 
Sephadex G-100. The native enzyme had a molecular mass of above 1000 kDa. Peak A, which was eluted 
from hydroxyapa~te at 50 mM phosphate, was activated 37-fold by the detergent, SDS, while peak B which 
was eluted at 150 mM phosphate, was activated only Zfold. After dialysis against water, the B form showed 
restored ability to be activated by SDS (96fold with 0.04% SDS). The activated peak B was extremely 
sensitive to divalent and monovalent cations such as Ca *+, Mg*“, Na+, K+ and NH+4 as well as protease 
inhibitors such as leupeptin, chymostatin and DFP. These results suggest hat these proteases are generally 
latent in the cells and may be regulated by changes in the concentrations of cations in the cytosol. We call 
this new type of protease, ingensin. 
Porcine muscle Protease SDS-activation 
1. INTRODUCTION 
Several reports have indicated that the mam- 
malian cytosol contains neutral proteolytic activity 
which plays major roles in physiological protein 
turnover or regulation of enzyme activities. 
Ca2+-activated neutral protease is a typical in- 
tracellular cytosolic protease responsible for in- 
itiating the breakdown of a variety of cellular com- 
ponents [l--6]. A 230 kDa high-molecular mass 
neutral protease digested oxidized proteins rapidly 
[7]. 
One of the major problems encountered in 
assessing the physiological significance of these 
cytosolic proteases in the celI is that they require 
some factor(s) such as calcium ions, in the case of 
Ca*+-activated neutral protease, for their activity, 
otherwise all the cellular components would be 
randomly degraded without effecters. 
In the course of studying the role of cytosolic 
neutral proteases, two forms of succinyl-leu-leu- 
Val-Tyr-MCA-degrading enzymes from porcine 
skeletal muscle were separated and partially 
purified. The molecular masses of the two pro- 
teases were high and they were unique in their ac- 
tivation by SDS. In the presence of a high salt con- 
centration both forms were inactive towards the 
synthetic peptide. A low concentration of SDS in 
the absence of salt highly activated both forms, but 
the activation was reversed by the addition of 
10 mM cations. Here we present evidence that 
many factors regulate this newly-found cytosolic 
protease, named ‘ingensin’. 
2. MATERIALS AND METHODS 
2.1. Materials 
Succinyl-Leu-Leu-Val-Tyr-MCA, leupeptin, 
chymostatin and bestatin were from the Peptide 
Research Institute, Osaka. Ep475 (E-64-c) was a 
gift from Taisho Pharm., Ohmiya. DEAE- 
cellulose and Sephadex G-100 were obtained from 
Pharmacia. Hydroxyapatite was from Seikagaku 
Kogyo. 
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2.2. Assay of succinyl-Leu-Leu- Val-Tyr-MCA- 
degrading activity 
Succinyl-Leu-Leu-Val-Tyr-MCA-degrading ac- 
tivity was determined by measuring the 
fluorescence of liberated aminomethylcoumarin 
(AMC) from the peptide. The incubation mixture 
(100 ~1) contained 20 mM Tris-HCl, pH 8, and 
0.5 mM substrate dissolved in dimethylsulfoxide 
(DMSO). The concentration of DMSO never ex- 
ceeded 5%. After incubation at 37°C for 60 min, 
the reaction was terminated by the addition of 
100~1 of 10% SDS and 1.3 ml of 0.1 M Tris-HCl, 
pH 9. 
2.3. Isolation of enzymes 
Porcine skeletal muscle (200 g) was minced and 
homogenized in a Waring Blender with 5 vols of 
5 mM phosphate/O.1 M NaCl, pH 7.0. The 
homogenate was centrifuged at 8000 x g for 
30 min and the sediment was discarded. Cold 
acetone (1: 1 v/v) was added gradually to the 
cytosol while stirring, and the suspension was then 
centrifuged at 8000 x g for 20 min. The pellet was 
redissolved in distilled water and dialyzed against 
water overnight. The dialyzed sample was applied 
to a 200 ml column of DEAE-cellulose 
equilibrated with 5 mM phosphate/O.1 M NaCl, 
pH 7.0. Elution was performed with the same buf- 
fer until the breakthrough fractions appeared, and 
then with a linear gradient of 0.1-0.4 M NaCl in 
the same buffer (total 1200 ml). Fractions contain- 
ing enzyme activity were pooled and diluted 3-fold 
with water. The sample was applied to a 30 ml col- 
umn of hydroxyapatite equilibrated with 5 mM 
phosphate, pH 7.0. The column was developed 
with a linear gradient of 5-300 mM sodium 
phosphate buffer, pH 7.0. 
3. RESULTS 
3.1. Separation of two forms of proteolytic 
activity on hydroxyapatite 
Fig.1 shows the elution pattern of the enzymes 
from a hydroxyapatite column. Two activities were 
detected eluting separately from the column. The 
first peak (peak A) was eluted at 50 mM 
phosphate, while the second one (peak B) was at 
150 mM. As shown in table 1, peak A was ac- 
tivated 37-fold by the addition of SDS (optimal 
concentration: 0.04%). 
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Fig.1. Separation of porcine skeletal muscle succinyl- 
Leu-Leu-Val-Tyr-MCA-degrading activity into two 
peaks on a hydroxyapatite column. Active fractions 
from a DEAE-cellulose column were chromatographed 
on a hydroxyapatite column (2 x 10 cm) as described in 
section 2. Aliquots (501~1) were assayed for protease 
activity (o---o) at pH 8. The protein concentrations of 
column fractions (-) were determined from the 
absorbance at 280 nm. 
Table 1 
Stimulation of Succinyl-Leu-Leu-Val-Tyr-MCA- 
degrading activity by 0.04% SDS 
Enzyme Activity Activation 
(-fold) 
No + 0.04% 
addition SDS 
(nmol (nmol 
AMC/h) AMC/h) 
Peak A 0.805 30.3 31 
Peak B 0.580 0.967 1.7 
Peaks A and B from Sephadex G-100 columns of fig.2 
were incubated as described in section 2. After 
incubation (37”C, 60 min), the liberated AMC was 
determined fluorometrically 
3.2. Molecular mass determination 
For further purification and molecular mass 
determination, the peak fractions from the 
hydroxyapatite column were applied to a column 
of Sephadex G-100 equilibrated with 5 mM 
phosphate, pH 7.0, with 0.1 M NaCl (fig.2). The 
succinyl-Leu-Leu-Val-Tyr-MCA-degrading activi- 
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Fig.2 Chromatography of suc~i~~E~eu-~eu-VaI-Tyr- 
~CA~e~rad~g activity on a Sephadex C-100 cohrmn. 
Fractions 20 (peak A) and 4Q (peak B) shown hi fig-l 
(5.5 ml) were ~~o~to~~h~ on a Sephadex C-l@@ 
coknnn (2 x 50 cm), Fractions of 55 ml were coBected 
and ahquots (Z&pi) were assayed for protease activity 
(o---m). 
ty was eluted near the void fraction, suggesting 
that the native molecular masses of these protease 
forms were above 100 kDa. The molecular mass of 
this protease, ingensin, was determined by HPLC 
on a TSK G3~W &umn ffig.3), A V&X of 
betw~n RXB and I300 kDa was obtained. The pH 
optimum of the ~t~de-hy~o~~~i~~ activity was 
between 8 and fO. 
3,3. Effect of protease inhibitors and ccrtions 
To further characterize the nature of the SDS ae- 
tivatian, the effect of various protease inhibitors 
on the peak B protease was investigated, 
As shown in table 2, chymostatin as well as 
Ieupeptin at 0.1 mg/ml significantly inhibited the 
SDS-activated form, A cysteine protease inhibitor, 
E4+c, and an ~~nu~~t~dase inhibitor, bestatin, 
at 0, f mgi’ml did not inhibit ingensin B b&h in the 
presence and absence of SDS. However, DFF at 
the concentration of 5 mM strongly inhibited both 
Fraction Number 
Fig.3. Molecular mass determination of the protease, 
ingensin, by HPLC (TSK 3OOOSW), Ferritin (F), 
catalase (C), h&ate dehydrogenase (LDFQ, ovalbumin 
@JV) and soybaan trypsin inhibitor (STL) were used as 
standards. Blue dextran was ehned at fraction 20. 
Table 2 
Percentage activity in the presence of various protease 
inhibitors 
Additions Sue-Leu-Leu-Val-“ryr-- 
MCA-deans activity 
(Qlc) 
- SDS + SDS 
No addition (1Qfr) 961 
Leupeptin (10 &g/ml) 78 9s 
Antipain (BXI &ml) 25 4 
Chymostatin (JO0 ,&ml) 15 3 
Pepstatin (100 fig/ml) 100 960 
Bestatin (lOa fig/ml) 100 960 
E-64-c (100 @/ml) 100 9155 
DFP (5 mh4) 0 Q 
Peak fractions of hrgensin B from a G-100 c&mm were 
incubated in the presence of the indicated ~n~~b~tors~ 
Enzyme activity was measured under the same c(fftdi- 
tions as described in table I_ FinaL ~n~n~~ti~~ of SDS 
was adjusted to 0.04% 
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forms. Thus, this peak B protease appears not to 
be a cysteine protease but a serine protease. 
Monovalent and divalent cations tested at 
10 mM and 1 mM, respectively, inhibited the SDS- 
activated form of peak B (table 3). The inhibition 
was greater with divalent cations such as Ca2+ and 
Table 3 
Effects of various salts, lipids, proteins and detergents 
on Sue-Leu-Leu-V~-Tyr-MCA-degrading activity of 
ingensin B 
Additions Percentage activity 
- SDS + SDS 
(0.04%) 
No addition 
2-Mercaptoethanol (10 mM) 
Dithiothreitol (10 mM) 
ATP (2 mM) 
NaCI (10 mM) 
KC1 (10 mM) 
NH&l (10 mM) 
CaC12 (1 mM) 
MgCh (1 mM) 
SrCl2 (1 mM) 
EDTA (1 mM) 
Phosphatidylserine (100 pg/ml) 
Phosphatidylinositol 
(100 gg/ml) 
1,2-Diolein (100 pg/ml) 
Sphingomyelin (100 pg/ml) 
Palmitic acid (100 pg/ml) 
Linoleic acid (100 pg/mI) 
Bovine serum albumin 
(i~~g/ml) 
Ovalbumin (100 pg/ml) 
Histone H2A (100 pglml) 
insulin (100 yglml) 
Soybean trypsin inhibitor 
(100 /rg/rnl) 
Deoxycholate (0.04%) 
N-Lauroylsarcosine Na 
Triton X-100 (0.04%) 
Triton X-303 (0.04%) 
Triton X-405 (0.04%) 
Triton N-101 (0.04%) 
Nonidet P-40 (0.04%) 
(0.04%) 
100 961 
100 1730 
100 1730 
81 672 
115 298 
113 278 
135 63 
203 153 
135 254 
149 203 
126 953 
110 N.D. 
113 N.D. 
100 N.D. 
100 N.D. 
100 N.D. 
650 N.D. 
100 917 
100 979 
44 679 
47 562 
100 960 
46 N.D. 
67 N.D. 
95 N.D. 
110 N.D. 
100 N.D. 
65 N.D. 
77 N.D. 
Peak fractions of ingensin B from a Sephadex G-100 
column were incubated as described in table 1. fngensin 
activity was expressed as a percentage of the control in 
the absence of effecters. N.D., not determined 
Mg2+ than with monovalent ones. EDTA did not 
have an inhibitory effect. However, these cations 
rather enhanced the latent peak B activity. At 
physiological concentrations of the ions, the activi- 
ty of peak B was twice that of the latent form. 
ATP added as the Na+ inhibited the SDS-activated 
form. This inhibition can be explained on the basis 
of the increased concentration of Na+ in the assay 
mixture. So far we have not found evidence that 
ATP itself activates the enzyme. Phospholipids 
and related compounds such as phosphatidyl- 
serine, phosphatidylinositol~ 1 ,Z-diolein and 
phosphatidylethanolamine (not shown) did not af- 
fect the activity of ingensin in the absence of SDS. 
However, linoleic acid added at above lOO/rg/ml 
activated ingensin 6.5fold. Table 3 also shows that 
proteins such as bovine serum albumin, oval- 
bumin, etc. and detergents other than SDS tested 
had no stimulatory effect on peptide hydrolysis by 
ingensin. Peak A showed essentially the same 
activity profile. 
4. DISCUSSION 
An N-terminus-blocked tetrapeptide-MCA, 
succinyl-Leu-Leu-Val-Tyr-MCA, has been shown 
to be a substrate for a number of neutral proteases. 
For example, chymotrypsin and Ca2+-activated 
neutral protease can hydrolyze this peptide-MCA 
[6]. It thus became apparent that this substrate is 
a sensitive indicator for chymotrypsin-type en- 
doprotease [8]. 
Here we found for the first time that porcine 
skeletal muscle contains two succinyl-leu-leu- 
Val-To-MCA-degrading activities. The prelimi- 
nary results indicated that human placenta and 
uterus and rat lung, liver and brain also contained 
this new protease, ingensin. Therefore the presence 
of ingensin in the mammalian cytosol is ubi- 
quitous. In human placenta and rat liver, we could 
detect two ingensin peaks on hydroxyapatite 
columns (unpublished). The differences in 
physicochemical properties between the two peaks 
were very small except for the SDS-activation as 
shown in table 1. A proteinase with properties 
similar to that reported here (ingensin B) has been 
recently identified in the rat skeletal muscle 19, lo]. 
Those authors described an SDS-activated enzyme. 
However, in contrast with our enzymes from por- 
cine skeletal muscle, the enzyme from rat skeletal 
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muscle is a cysteine proteinase. Although some 
further differences exist with respect to the 
catalytic properties, the rat and the porcine en- 
zymes seem to be essentially similar. 
Evidence that the peak B protease activity is in- 
fluenced by a small amount of SDS and cations 
may be important as to the regulation of protein 
breakdown within living cells. The effect of SDS 
suggests that a slight conformational change ac- 
tivates the enzyme, but the active conformation 
may be labile because a small alteration of the 
ionic environment immediately disactivates the en- 
zyme. Muscle cells contain about 36 mM Na+ and 
92 mM K+. Therefore the enzyme in physiological 
conditions remains in a less active form which may 
be reasonable for the cells. Inhibition of the pro- 
teolytic activity by cations could be of 
physiological significance if some factor(s) like a 
linoleic acid in the cell act as a substitute for SDS. 
We are currently searching for such substances. 
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